MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, TEVJF made $3,982M in revenue. $369M in net income. Net profit margin of 9.27%.

Income Overview

Revenue
$3,982M
Net Income
$369M
Net Profit Margin
9.27%
EPS
$0.31
Unit: Million (M) dollars
Revenue Breakdown
    • US
    • Europe
    • Other Activities
    • International Markets

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net revenues
3,982 4,704* 4,480 -
Cost of sales
2,011 2,035* 2,176 -
Gross profit
1,972 2,669* 2,304 -
Research and development expenses
222 259* 256 -
Selling and marketing expenses
696 769* 656 -
General and administrative expenses
304 366* 317 -
Intangible assets impairments
8 -18* 64 -
Goodwill impairment
-0* 0 -
Other assets impairments, restructuring and other items
26 990* 62 -
Legal settlements and loss contingencies
72 248* 60 -
Other loss (income)
9 0* -7 -
Operating income (loss)
652 56* 882 -
Financial expenses, net
-216 -242* -237 -
Income (gain) before income taxes
437 -187* 646 -
Adjustments to valuation allowances on deferred tax assets-Revenue Commissioners Ireland
-10* --
Other (amount)-Revenue Commissioners Ireland
--1* --
Statutory tax rate difference (amount)-Malta Tax Authority
-9* --
Reduced rate due to imputation system (amount)-Malta Tax Authority
-22* --
Other (amount)-Malta Tax Authority
-2* --
Adjustments to valuation allowances on deferred tax assets-Tax And Customs Administration Netherlands
-35* --
Other (amount)-Tax And Customs Administration Netherlands
-0* --
Statutory tax rate difference (amount)-Swiss Federal Tax Administration FTA
--40* --
Adjustments to valuation allowances on deferred tax assets-Swiss Federal Tax Administration FTA
--8* --
Other (amount)-Swiss Federal Tax Administration FTA
-1* --
Changes in unrecognized tax benefits (amount)-Other Countries Tax Authority
-15* --
Adjustments to valuation allowances on deferred tax assets-Other Countries Tax Authority
-661* --
Income taxes (benefit)
67 -659* 214 -
Share in (profits) losses of associated companies net
-1 9* 2 -
Net income (loss)
369 481 434 283
Net income (gain) attributable to redeemable and non-redeemable non-controlling interests
-0 1 -
Net income (loss) attributable to teva
369 481 433 282
Basic EPS
0.32 0.419 0.38 0.25
Diluted EPS
0.31 0.412 0.37 0.24
Basic Average Shares
1,156,000,000 1,148,000,000 1,147,000,000 1,147,000,000
Diluted Average Shares
1,179,000,000 1,168,000,000 1,164,000,000 1,161,000,000
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
US$1,534M (-19.69%↓ Y/Y)Europe$1,340M (12.23%↑ Y/Y)Other Activities$584M (183.50%↑ Y/Y)International Markets$524M (-9.97%↓ Y/Y)Net revenues$3,982M (2.34%↑ Y/Y)Gross profit$1,972M (5.06%↑ Y/Y)Other loss (income)$9M (280.00%↑ Y/Y)Cost of sales$2,011M (-0.15%↓ Y/Y)Operating income (loss)$652M (25.63%↑ Y/Y)Selling and marketingexpenses$696M (11.90%↑ Y/Y)General andadministrative expenses$304M (2.36%↑ Y/Y)Research and developmentexpenses$222M (-10.12%↓ Y/Y)Legal settlements andloss contingencies$72M (-16.28%↓ Y/Y)Other assetsimpairments, restructuring...$26M (218.18%↑ Y/Y)Intangible assetsimpairments$8M (-93.39%↓ Y/Y)Income (gain) beforeincome taxes$437M (48.64%↑ Y/Y)Financial expenses, net-$216M (4.00%↑ Y/Y)Net income (loss)$369M (67.73%↑ Y/Y)Income taxes (benefit)$67M (-9.46%↓ Y/Y)Share in (profits)losses of associated...-$1M Net income (loss)attributable to teva$369M (72.43%↑ Y/Y)

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF)

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF)